Cansartan-Mepha 4

Cansartan-Mepha 4 is a medicine authorised by Swissmedic under authorisation number 60929. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 November 2010 and the authorisation is valid without a time limit. ATC code C09CA06 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 60929
  • ATC C09CA06
  • Synthetic medicines
Authorisation data
Authorisation number60929
NameCansartan-Mepha 4
Full nameCansartan-Mepha 4, Tabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09CA06
First authorisation30 November 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Cansartan-Mepha 4, TablettenB30 November 2010
2Cansartan-Mepha 8, TablettenB30 November 2010
3Cansartan-Mepha 16, TablettenB30 November 2010
4Cansartan-Mepha 32, TablettenB30 November 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
87Tablette(n)C09CA0602.07.1.B
928Tablette(n)C09CA0602.07.1.B
1098Tablette(n)C09CA0602.07.1.B
1128Tablette(n)C09CA0602.07.1.B
1298Tablette(n)C09CA0602.07.1.B
1328Tablette(n)C09CA0602.07.1.B
1498Tablette(n)C09CA0602.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cansartan-Mepha 4 authorised in Switzerland?

Yes. Cansartan-Mepha 4 is authorised by Swissmedic under authorisation number 60929, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Cansartan-Mepha 4 have?

Cansartan-Mepha 4 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Cansartan-Mepha 4?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com